Cerecor Inc. Granted U.S. Patent for Antitussive FP01
8/9/2013 9:31:30 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
BALTIMORE--(BUSINESS WIRE)--Cerecor Inc., a biopharmaceutical company developing neuroscience drugs that target underserved patient segments of common diseases, today announced that the United States Patent and Trademark Office (USPTO) issued the Company’s U.S. Patent No. 8,501,816 which includes claims covering its antitussive, FP01.
Help employers find you! Check out all the jobs and post your resume.
comments powered by